IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Relapsed or Refractory Marginal Zone B-cell Lymphoma

Korea Cancer Center Hospitalmonoclonal_antibodyPhase 2Dormant

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 95/ 100

Competitive context

106 Active assets in the Relapsed or Refractory Marginal Zone B-cell Lymphoma cohort.

Asset / Sponsor	Phase	Rating
ETOPOSIDE University of Miami	Phase 2	BBB
Orelabrutinib Henan Cancer Hospital	Phase 4	BBB
Fludarabine Paolo Caimi, MD	Phase 2	BBB
FILGRASTIM Fred Hutchinson Cancer Center	Phase 2	BBB
CYCLOSPORIN A Fred Hutchinson Cancer Center	Phase 2	BBB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB